8-K filed Feb 25, 2026
Synopsys authorizes $2B for stock buybacks
“Synopsys’ board of directors approved a replenishment of the existing stock repurchase program with authorization to purchase up to $2.0 billion of Synopsys common stock”
From Synopsys’s 8-K filed Feb 25, 2026 · read the filing · all documents
How big is it?
Synopsys bought back $38M of stock in the twelve months to Jul 31, 2026. At that pace, $2.0B covers about 53.3 years of buybacks.
The amount equals 73% of its free cash flow over the same twelve months ($2.7B).
Its diluted share count is up 18.9% from a year earlier.
An authorization is permission, not a promise: the company can buy less, more slowly, or not at all, and usually doesn't have to say when it buys.
Show as table
| Period | Value |
|---|---|
| Q4 '23 | $300M |
| Q1 '24 | $0 |
| Q2 '24 | $0 |
| Q3 '24 | $0 |
| Q4 '24 | $0 |
| Q1 '25 | $0 |
| Q2 '25 | $0 |
| Q3 '25 | $0 |
| Q4 '25 | $0 |
| Q1 '26 | $0 |
| Q2 '26 | $0 |
| Q3 '26 | $37.5M |